Literature DB >> 31554644

Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products.

Dongdong Wang1, Yang Yang1, Yingnan Lei1, Nikolay T Tzvetkov1, Xingde Liu1, Andy Wai Kan Yeung1, Suowen Xu2, Atanas G Atanasov3.   

Abstract

Foam cell formation and further accumulation in the subendothelial space of the vascular wall is a hallmark of atherosclerotic lesions. Targeting foam cell formation in the atherosclerotic lesions can be a promising approach to treat and prevent atherosclerosis. The formation of foam cells is determined by the balanced effects of three major interrelated biologic processes, including lipid uptake, cholesterol esterification, and cholesterol efflux. Natural products are a promising source for new lead structures. Multiple natural products and pharmaceutical agents can inhibit foam cell formation and thus exhibit antiatherosclerotic capacity by suppressing lipid uptake, cholesterol esterification, and/or promoting cholesterol ester hydrolysis and cholesterol efflux. This review summarizes recent findings on these three biologic processes and natural products with demonstrated potential to target such processes. Discussed also are potential future directions for studying the mechanisms of foam cell formation and the development of foam cell-targeted therapeutic strategies.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31554644     DOI: 10.1124/pr.118.017178

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  31 in total

1.  Atherosclerosis: Pathogenesis and Key Cellular Processes, Current and Emerging Therapies, Key Challenges, and Future Research Directions.

Authors:  Yee-Hung Chan; Dipak P Ramji
Journal:  Methods Mol Biol       Date:  2022

2.  Accumulation of LDL/ox-LDL in the necrotic region participates in osteonecrosis of the femoral head: a pathological and in vitro study.

Authors:  Xin-Yuan Wang; Tian-Le Ma; Kang-Ning Chen; Zhi-Ying Pang; Hao Wang; Jun-Ming Huang; Guo-Bin Qi; Chen-Zhong Wang; Zeng-Xin Jiang; Lin-Jing Gong; Zhe Wang; Chang Jiang; Zuo-Qin Yan
Journal:  Lipids Health Dis       Date:  2021-11-25       Impact factor: 3.876

Review 3.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

4.  APE1 inhibits foam cell formation from macrophages via LOX1 suppression.

Authors:  Zhaohui Hu; Bo Hui; Xuwei Hou; Ruhui Liu; Sergiy Sukhanov; Xiaohong Liu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 5.  GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.

Authors:  Dongdong Wang; Emily A Day; Logan K Townsend; Djordje Djordjevic; Sebastian Beck Jørgensen; Gregory R Steinberg
Journal:  Nat Rev Endocrinol       Date:  2021-08-11       Impact factor: 43.330

6.  Septin 4 activates PPARγ/LXRα signaling by upregulating ABCA1 and ABCG1 expression to inhibit the formation of THP-1 macrophage-derived foam cells.

Authors:  Xiaoying Song; Guoliang Yan; Haihui Wang; Danfei Lou
Journal:  Exp Ther Med       Date:  2021-05-13       Impact factor: 2.447

Review 7.  A novel therapeutic strategy for atherosclerosis: autophagy-dependent cholesterol efflux.

Authors:  Haipeng Guo; Dongmei Wei; Rui Liu; Chao Zhang; Song Jiang; Weijia Wang; Hongzhe Hu; Lijuan Shen; Xiaofei Liang
Journal:  J Physiol Biochem       Date:  2022-01-22       Impact factor: 5.080

8.  BTK Promotes Atherosclerosis by Regulating Oxidative Stress, Mitochondrial Injury, and ER Stress of Macrophages.

Authors:  Junxiong Qiu; Yuan Fu; Zhiteng Chen; Lisui Zhang; Ling Li; Diefei Liang; Feng Wei; Zhuzhi Wen; Yajing Wang; Shi Liang
Journal:  Oxid Med Cell Longev       Date:  2021-05-27       Impact factor: 6.543

Review 9.  Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota.

Authors:  Shengjie Yang; Dan Li; Zongliang Yu; Yujuan Li; Min Wu
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

Review 10.  Recent Advancements in CD47 Signal Transduction Pathways Involved in Vascular Diseases.

Authors:  Manman Dou; Ying Chen; Jian Hu; Di Ma; Yingqi Xing
Journal:  Biomed Res Int       Date:  2020-07-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.